Ipca Laboratories Ltd NSE  /  BSE

Pharmaceuticals, Mid Cap

26 Feb 2021 | 04:00 PM

1,849.30
-16.20 (-0.87%)

  • Underperforms Index

    36.89%

    Return (1Y)

    Underperformed S&P BSE Healthcare by 13.06%

  • More Volatile

    2.75%

    Standard Deviation (1Y)

    Higher than S&P BSE Healthcare by 1.01%

  • Not so consistent

    5/12

    Months

    underperformed S&P BSE Healthcare

  • AxisDirect View

    No View

52 Week High-Low

2,456

2,455.55

1,162

1,162.00

News & Announcements

Price vs Volume

Stock Trivia

  • FII shareholding in Ipca Laboratories Ltd has increased by 46.91% since past 3 Months

  • MF shareholding in Ipca Laboratories Ltd has decreased by -12.55% since past 3 Months

  • FII shareholding in Ipca Laboratories Ltd has increased by 30.25% since past 1 Year

  • MF shareholding in Ipca Laboratories Ltd has decreased by -9.59% since past 1 Year

Loading...